XT
HKPD

XTX Topco’s Cellyan Biotechnology HKPD Stock Holding History

XTX Topco’s Portfolio HKPD Stock Details HKPD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Buy
+38,930
New +$21.3K ﹤0.01% 3964

Other funds holding HKPD

SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco's HKPD Position: Q2 2026 in Review

XTX Topco opened a new position in Cellyan Biotechnology (HKPD) in Q2 2026: 38,930 shares worth $14.8K. The stake represents ﹤0.01% of the portfolio and ranks #3964 among its holdings.

6 funds tracked by Wall St. Rank hold HKPD as of Q2 2026.

  • XTX Topco held 38,930 shares of Cellyan Biotechnology worth $14.8K as of Q2 2026.
  • Cellyan Biotechnology was a new XTX Topco position in Q2 2026.
  • Cellyan Biotechnology made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3964 holding.
  • 6 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.